Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07187245 · ClinicalTrials.gov registry record · NA

Feasibility of the Reality PAWS Program for Children in Isolation

A NA study, sponsored by Children's Hospital Colorado.

Recruiting
Registry status
NA
Development phase
50
Enrollment target

NCT07187245: Recruiting NA study, sponsored by Children's Hospital Colorado.

NCT07187245 is a NA study that is actively recruiting participants, run by Children's Hospital Colorado. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07187245, a NA study, is actively recruiting participants, sponsored by Children's Hospital Colorado.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if a mixed reality program, Reality PAWS, delivered on a Meta Quest 3 VR headset, is a feasible intervention for pediatric patients in isolation. It will also evaluate the safety of the program and its effect on pain, anxiety, and loneliness. The main questions the study aims to answer are: What is the feasibility of utilizing Reality PAWS MR as a substitute for in-person dog therapy for children under isolation precautions? Are patients compliant with using Reality PAWS MR? What are the interventional outcomes of Reality PAWS MR? Participants will: Wear a Meta Quest 3 VR headset with the Reality PAWS program. Interact with the program. Answer surveys regarding demographics, anxiety, pain, loneliness, sickness, perceived exertion, and immersion in the program.

Primary Outcome

Number of screened patients, number of eligible patients, number of enrolled patients, number of withdrawn patients, number of subsequent Reality Paws sessions received/requested by patients.

Interventions

  • DEVICE Reality PAWS Program via Meta Quest 3 VR

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-01-29
Est. Completion 2026-07-01
Phase NA
Children's Hospital Colorado

7 total trials

What NCT07187245 shows while recruiting

NCT07187245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Reality PAWS Program via Meta Quest 3 VR is the first listed.

NCT07187245 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07187245 about?

NCT07187245 is a clinical study titled "Feasibility of the Reality PAWS Program for Children in Isolation". The goal of this clinical trial is to learn if a mixed reality program, Reality PAWS, delivered on a Meta Quest 3 VR headset, is a feasible intervention for pediatric patients in isolation. It will also evaluate the safety of the program and its effect on pain, anxiety, and loneliness. The main ques...

What is the current status of trial NCT07187245?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-01-29. Estimated completion is 2026-07-01.

What interventions are being tested in trial NCT07187245?

The interventions under investigation include: Reality PAWS Program via Meta Quest 3 VR (DEVICE).

Who is sponsoring clinical trial NCT07187245?

This trial is sponsored by Children's Hospital Colorado, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07187245's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07187245, the US trial registry maintained by the National Library of Medicine. NCT07187245 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.